In response to inflammatory stimuli, T1D ECFCs exhibited exaggerated pro‐atherogenic/pro‐inflammatory cytokine (IL‐6 and MCP‐1) and adhesion molecule gene induction (VCAM‐1 and ICAM‐1) but suppressed induction of interferon signaling markers (IP‐10). The gene discussed is CCL2; the disease is type 1 diabetes mellitus.